44 results
10-Q
2024 Q1
VS
Versus Systems Inc
15 May 24
Quarterly report
4:01pm
of revenues
Gross margin
EXPENSES
Research and development
Selling, general and administrative
Total operating expenses
Operating loss
Other income/(expense … to be sold. The costs incurred to establish the technological feasibility of the software that will be sold are expensed as research and development when
424B3
VS
Versus Systems Inc
29 Apr 24
Prospectus supplement
4:06pm
, manufacture and commercialize new products or achieve an acceptable return on our manufacturing or research and development efforts and expenses … considerable cost and effort in carrying out extensive research and development to assess the potential interest in our platform and to remain abreast
10-K
2023 FY
VS
Versus Systems Inc
1 Apr 24
Annual report
2:07pm
.
Research and Development
Our research and development team, including in-house and as-needed contract resources, consists of technical engineering … substantial resources in research and development to enhance our platform features and functionalities and expand the services we offer. We believe
10-K
2023 FY
EX-19.1
VS
Versus Systems Inc
1 Apr 24
Annual report
2:07pm
, suppliers, or strategic partners on issues such as research and development, sales and marketing, and supply contracts;
employees, officers and directors
S-4
9b4zs1v20hey12
16 Feb 24
Registration of securities issued in business combination transactions
5:32pm
6-K
EX-99.2
2f6ua1hutbi9d40c21v5
14 Nov 23
Condensed Interim Consolidated Financial Statements
4:22pm
6-K
EX-99.2
nhgz wj6dls18ood3jiu
14 Aug 23
Condensed Interim Consolidated Financial Statements
4:01pm
6-K
EX-99.2
5b1wsi3fbhfkm3 i8sg
15 May 23
Condensed Interim Consolidated Financial Statements
4:05pm
6-K
EX-99.2
y01akt
29 Mar 23
Consolidated Financial Statements
4:01pm
6-K
EX-99.2
7fp4oqxwai 57
14 Nov 22
Condensed Interim Consolidated Financial Statements
4:50pm
20-F/A
9l3cfg61eu6n8
23 Aug 22
Annual report (foreign) (amended)
4:15pm
6-K
EX-99.2
zaj9g
15 Aug 22
Condensed Interim Consolidated Financial Statements
4:03pm
424B5
sjp5m0x bb87gvgl
15 Jul 22
Prospectus supplement for primary offering
5:20pm
6-K
EX-99.2
xyhne3fi
16 May 22
Condensed Interim Consolidated Financial Statements
7:24pm
6-K
EX-99.2
jat 5egsyzih
1 Apr 22
Consolidated Financial Statements
9:10pm
424B4
4pf wvu4ddu
24 Feb 22
Prospectus supplement with pricing info
4:02pm
POS AM
8k2hmiozejdexq s2
1 Feb 22
Prospectus update (post-effective amendment)
5:29pm